MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
Jardim DL, de Melo Gagliato D, Falchook GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S, Murphy MB, Ajani J, Tang C, Hess K, Hamilton SR, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS.
Jardim DL, et al. Among authors: wheler jj.
Oncotarget. 2014 Apr 15;5(7):1837-45. doi: 10.18632/oncotarget.1828.
Oncotarget. 2014.
PMID: 24742823
Free PMC article.
Clinical Trial.